EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study)

Tatsuo Akechi iD, Takuhiro Yamaguchi, Megumi Uchida, Fuminobu Imai iD, Kanae Momino iD, Fujika Katsuki, Naomi Sakurai, Tempei Miyaji, Tomoe Mashiko, Masaru Horikoshi, Toshi A Furukawa, Akiyo Yoshimura iD und 7 weitere

Journal of Clinical Oncology · 10.02.2023 · 41 (5) · 1069-1078

DOI: 10.1200/jco.22.00699 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.02.2023. Verfasst von Tatsuo Akechi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Cancer Survivors. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Fear of cancer recurrence (FCR) is a common distressing condition. We investigated the efficacy of smartphone problem-solving therapy and behavioral activation applications in breast cancer survivors. METHODS This was a decentralized randomized trial. Participants were disease-free breast cancer survivors age 20-49 years who were randomly assigned to the smartphone-based intervention or waitlist control. Both groups received treatment as usual. The control group could access the smartphone apps during weeks 8-24. The intervention comprised smartphone problem-solving therapy and behavioral activation apps. The primary end point was the Concerns About Recurrence Scale at week 8. Secondary outcomes included the Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF), the Hospital Anxiety and Depression Scale (HADS), the Short-form Supportive Care Needs Survey (SCNS-SF34), and the Posttraumatic Growth Inventory at weeks 8 and 24 (trial registration: UMIN-CTR: UMIN000031140). RESULTS The intervention group included 223 participants, and the control group included 224 participants. Primary outcome data were obtained for 444 participants, and 213 participants in the intervention arm completed the week 24 assessment. The intervention group had statistically greater improvements than controls at week 8 on the Concerns About Recurrence Scale (difference –1.39; 95% CI, –1.93 to –0.85; P < .001), FCRI-SF (difference –1.65; 95% CI, –2.41 to –0.89; P < .001), HADS depression (difference –0.49; 95% CI, –0.98 to 0; P < .05), and SCNS-SF34 psychological domain (difference –1.49; 95% CI, –2.67 to –0.32; P < .05). These scores at week 24 were not statistically significant compared with week 8 although the HADS depression score at week 24 was significantly reduced ( P = .03). CONCLUSION Novel smartphone psychotherapy offers a promising way to reduce FCR given the large number of survivors and a limited number of therapists to competently conduct psychotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCancer SurvivorsHumansYoung AdultAdultMiddle AgedFemaleSmartphoneNeoplasm Recurrence, LocalFearPsychotherapySurvivors

Autor:innen und Institutionen

  • Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Division of Palliative Care and Psycho-oncology, Nagoya City University Hospital, Nagoya, Japan.
  • Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Department of Nursing Administration and Management, Nagoya City University Graduate School of Nursing, Nagoya, Japan.
  • Department of Psychiatric and Mental Health Nursing, Nagoya City University Graduate School of Nursing, Nagoya, Japan.
  • Cancer Solutions Co, Ltd, Tokyo, Japan.

ORCID-Profile: Tatsuo Akechi, Fuminobu Imai, Kanae Momino, Akiyo Yoshimura, Shinji Ohno, Hiroji Iwata

Zitieren

APA

Akechi, T., Yamaguchi, T., Uchida, M., Imai, F., Momino, K., Katsuki, F., Sakurai, N., Miyaji, T., Mashiko, T., Horikoshi, M., Furukawa, T. A., Yoshimura, A., Ohno, S., Uehiro, N., Higaki, K., Hasegawa, Y., Akahane, K., Uchitomi, Y., & Iwata, H. (2023). Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study). Journal of Clinical Oncology, 41(5), 1069-1078. https://doi.org/10.1200/jco.22.00699

Vancouver

Akechi T, Yamaguchi T, Uchida M, Imai F, Momino K, Katsuki F, et al. Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study). Journal of Clinical Oncology. 2023;41(5):1069-1078. doi:10.1200/jco.22.00699

BibTeX
@article{Akechi2023,
  author = {Akechi, Tatsuo and Yamaguchi, Takuhiro and Uchida, Megumi and Imai, Fuminobu and Momino, Kanae and Katsuki, Fujika and Sakurai, Naomi and Miyaji, Tempei and Mashiko, Tomoe and Horikoshi, Masaru and Furukawa, Toshi A and Yoshimura, Akiyo and Ohno, Shinji and Uehiro, Natsue and Higaki, Kenji and Hasegawa, Yoshie and Akahane, Kazuhisa and Uchitomi, Yosuke and Iwata, Hiroji},
  title = {Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study)},
  journal = {Journal of Clinical Oncology},
  year = {2023},
  volume = {41},
  number = {5},
  pages = {1069--1078},
  doi = {10.1200/jco.22.00699}
}
Kostenlos starten →